← Back to Search

Active Implementation phase for Uterine Fibroids (UPFRONT Trial)

N/A
Waitlist Available
Led By Glyn Elwyn, MD, PhD
Research Sponsored by Dartmouth-Hitchcock Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through month 1-6, month 8-14
Awards & highlights

UPFRONT Trial Summary

This study is evaluating whether a patient decision aid can help women make decisions about uterine fibroids.

Eligible Conditions
  • Uterine Fibroids

UPFRONT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through month 1-6, month 8-14
This trial's timeline: 3 weeks for screening, Varies for treatment, and through month 1-6, month 8-14 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
The number of eligible patients that can be identified who receive the uterine fibroid Option Grid patient decision aid.
Secondary outcome measures
Attitudes toward Decision Aids fOr PatienTs (ADOPT)
Chew Health Literacy Measure
Fidelity assessment
+10 more

UPFRONT Trial Design

1Treatment groups
Experimental Treatment
Group I: Active Implementation phaseExperimental Treatment3 Interventions
See the 'detailed description' section to read about the intervention(s) clinicians will use during the active implementation phase of the randomized stepped-wedge design.

Find a Location

Who is running the clinical trial?

Montefiore Medical CenterOTHER
441 Previous Clinical Trials
581,448 Total Patients Enrolled
Brigham and Women's HospitalOTHER
1,609 Previous Clinical Trials
11,469,579 Total Patients Enrolled
Mayo ClinicOTHER
3,206 Previous Clinical Trials
3,766,335 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Implementation ScienceJournal
Implementation of the Uterine Fibroids Option Grid Patient Decision Aids Across Five Organizational Settings: A Randomized Stepped-wedge Study Protocol
Scalia, Peter, Marie-Anne Durand, Rachel C. Forcino, Danielle Schubbe, Paul J. Barr, Nancy O’Brien, A. James O’Malley, et al.. 2019. “Implementation of the Uterine Fibroids Option Grid Patient Decision Aids Across Five Organizational Settings: A Randomized Stepped-wedge Study Protocol”. Implementation Science. Springer Science and Business Media LLC. doi:10.1186/s13012-019-0933-z.
clinicaltrials.govStudy
Implementation of Uterine Fibroid Option Grid Patient Decision Aids Across Five Organizational Settings
Glyn Jones-Elwyn 2019. "Implementation of Uterine Fibroid Option Grid Patient Decision Aids Across Five Organizational Settings". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03985449.
~132 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top